Exozymes Inc.: director Bowie James Ulrich received 10,000 shares

What happened The Form 4 reports that Bowie James Ulrich, a director, was granted 10,000 shares as a derivative award on Oct 1, 2026, at $0.00 per share, total $0 (transaction code A).

Key details

• Transaction date: Oct 1, 2026; price: $0.00 per share; total reported value: $0.
• The filing describes the award as a derivative option grant.
• Shares owned after the transaction: the filing does not report post-transaction ownership.
• Footnote F1: the option vests in 12 quarterly installments (11 installments of 833 shares and a final installment of 837 shares), beginning on Dec 31, 2026 and ending on Sep 30, 2029, subject to continued service. The option expires on Oct 1, 2033.
• Form filed on Oct 19, 2026 (transaction date Oct 1, 2026).

Why it may matter

• This was an option grant that vests over time rather than an immediate market sale.
• The grant is subject to continued service and an expiration date of Oct 1, 2033.
• A filing does not show why the insider traded or why the company acted.